IP Library Patent Application 12831111
Patent Application
App. No. 12/831,111

NOVEL SYNTHETIC GANGLIOSIDE DERIVATIVES AND COMPOSITIONS THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/831,111
Abstract

Novel synthetic gangliosides and pharmaceutical compositions containing such synthetic gangliosides are described. Methods of making the novel synthetic ganglioside compounds and compositions as well as their use in the field of neuroprotection and cancer treatment is also described.

Claims (18)

1 - 22 . (canceled)

23 . A synthetic compound having a formula selected from the group consisting of (Va), (Vb), (Vc) and (Vd):

wherein

the saccharide portion is selected from the group consisting of a monosaccharide, a disaccharide, an oligosaccharide, a polysaccharide, an N-acetylated derivative thereof and an N-deacetylated derivative thereof;

X is NR 1 R 2 ;

Y is —OH;

Z is O;

each R 1 and R 2 are independently selected from the group consisting of —C(=M)R 3 , and —C(=M)-p-R 3 ;

wherein M and p are independently selected from O, NR 4 and S;

R 3 is H, alkyl, arylalkyl, haloalkyl, aryl, heteroaryl, or heteroalkyl;

R 4 is H, alkyl, aryl, arylalkyl, heteroaryl, heteroalkyl, or haloalkyl;

R 6 is H;

R 6′ is —NR 9 R 10 ;

R 6″ is H;

R 7 and R 8 are independently H, and aryl, where, R 7 and R 8 are optionally substituted with at least one group selected from the group consisting of halo, haloalkyl, alkoxy, and thiohaloalkyl;

R 7′ and R 8′ are independently H, alkenyl, —C(═O)NR 9 R 10 , aryl, heteroaryl, or a linked bicyclic mixture of aryl and heteroaryl, where R 7′ and R 8′ are optionally substituted with at least one group selected from the group consisting of halo, haloalkyl, alkoxy, and thiohaloalkyl;

R 9 , R 10 , and R 11 are independently alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, or heteroalkyl, where R 9 , R 10 , and R 11 are optionally substituted, preferably-substituted with at least one group selected from the group consisting of halo, haloalkyl, alkoxy, and thiohaloalkyl; or where R 9 and R 10 taken together with the nitrogen to which they are attached form a heterocyclic ring comprising at least one heteroatom selected from N, O and S;

and all pharmaceutically acceptable salts, hydrates, geometric isomers and solvates thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2019
From: SENEB BIOSCIENCES, INC.
To: LA JOLLA PHARMACEUTICAL COMPANY
Reel/Frame 048121/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2010
From: DEFREES, SHAWN; WANG, ZHI-GUANG
To: SENEB BIOSCIENCES, INC.
Reel/Frame 024759/0023 →